Anne Sofie Dam Laursen

Anne Sofie Dam Laursen

Auto-generated profile, based on publicly available information

Anne Sofie Dam Laursen

Department of Clinical Epidemiology and Population Medicine, Aarhus University and Aarhus University Hospital , Aarhus

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2014 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
ALA. S. Dam Laursen
A. S. Dam Laursen
CVC. Vidal
C. Vidal
TST. Skaaby
T. Skaaby
FGF. Gude
F. Gude
Allan LinnebergAllan Linneberg
Allan Linneberg

1 March 2019 in International Journal of Cardiology
Verified
Journal Article
Open access
JPJaike Praagman
Jaike Praagman
LVLinda E.T. Vissers
Linda E.T. Vissers
AMAngela A. Mulligan
Angela A. Mulligan
ALAnne Sofie Dam Laursen
Anne Sofie Dam Laursen
JBJoline W.J. Beulens
Joline W.J. Beulens
ISIvonne Sluijs
Ivonne Sluijs
The effect of individual saturated fatty acids (SFAs) on serum cholesterol levels depends on their carbon-chain length. Whether the association with myocardial infarction (MI) also differs across individual SFAs is unclear. We examined the association between consumption of individual SFAs, differing in chain lengths ranging from 4 through 18 carbons, and risk of MI. We used data from 22,050 and 53,375 participants from EPIC-Norfolk (UK) and EPIC-Denmark, respectively. Baseline SFA intakes were assessed through validated, country-specific food frequency questionnaires. Cox regression analysis was used to estimate associations between intakes of individual SFAs and MI risk, for each cohort separately. During median follow-up times of 18.8 years in EPIC-Norfolk and 13.6 years in Denmark, respectively, 1204 and 2260 MI events occurred. Mean (±SD) total SFA intake was 13.3 (±3.5) en% in EPIC-Norfolk, and 12.5 (±2.6) en% in EPIC-Denmark. After multivariable adjustment, intakes of C12:0 (lauric acid) and C14:0 (myristic acid) inversely associated with MI risk in EPIC-Denmark (HR upper versus lowest quintile: 0.80 (95%CI: 0.66, 0.96) for both SFAs). Intakes in the third and fourth quintiles of C4:0-C10:0 also associated with lower MI risk in EPIC-Denmark. Moreover, substitution of C16:0 (palmitic acid) and C18:0 (stearic acid) with plant proteins resulted in a reduction of MI risk in EPIC-Denmark (HR per 1 energy%: 0.86 (95%CI: 0.78, 0.95) and 0.87 (95%CI: 0.79, 0.96) respectively). No such associations were found in EPIC-Norfolk. The results from the present study suggest that the association between SFA and MI risk depends on the carbon chain-length of the SFA.

16 June 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
TDTalita Duarte‐Salles
Talita Duarte‐Salles
VFVeronika Fedirko
Veronika Fedirko
MSMagdalena Stepien
Magdalena Stepien
KAKrasimira Aleksandrova
Krasimira Aleksandrova
CBChristina Bamia
Christina Bamia
MJMazda Jenab
Mazda Jenab
The role of amount and type of dietary fat consumption in the etiology of hepatocellular carcinoma (HCC) is poorly understood, despite suggestive biological plausibility. The associations of total fat, fat subtypes and fat sources with HCC incidence were investigated in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, which includes 191 incident HCC cases diagnosed between 1992 and 2010. Diet was assessed by country‐specific, validated dietary questionnaires. A single 24‐hr diet recall from a cohort subsample was used for measurement error calibration. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated from Cox proportional hazard models. Hepatitis B and C viruses (HBV/HCV) status and biomarkers of liver function were assessed separately in a nested case–control subset with available blood samples (HCC = 122). In multivariable calibrated models, there was a statistically significant inverse association between total fat intake and risk of HCC (per 10 g/day, HR = 0.80, 95% CI: 0.65–0.99), which was mainly driven by monounsaturated fats (per 5 g/day, HR = 0.71, 95% CI: 0.55–0.92) rather than polyunsaturated fats (per 5 g/day, HR = 0.92, 95% CI: 0.68–1.25). There was no association between saturated fats (HR = 1.08, 95% CI: 0.88–1.34) and HCC risk. The ratio of polyunsaturated/monounsaturated fats to saturated fats was not significantly associated with HCC risk (per 0.2 point, HR = 0.86, 95% CI: 0.73–1.01). Restriction of analyses to HBV/HCV free participants or adjustment for liver function did not substantially alter the findings. In this large prospective European cohort, higher consumption of monounsaturated fats is associated with lower HCC risk.

23 March 2018 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
ABAnne S. Bertelsen
Anne S. Bertelsen
ALAnne Laursen
Anne Laursen
TKtine ahrendt knudsen
tine ahrendt knudsen
SMStine Møller
Stine Møller
UKUlla Kidmose
Ulla Kidmose

12 June 2017 in European Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
ALAnne Sofie Dam Laursen
Anne Sofie Dam Laursen
CDChristina C Dahm
Christina C Dahm
SJSøren Paaske Johnsen
Søren Paaske Johnsen
ATAnne Marie Tjønneland
Anne Marie Tjønneland
KOKim Overvad
Kim Overvad
Marianne Uhre JakobsenMarianne Uhre Jakobsen
Marianne Uhre Jakobsen

1 May 2020 in The Journal of Nutrition
Verified
Journal Article
Closed access
KKKarina Kvist
Karina Kvist
ALAnne Sofie Dam Laursen
Anne Sofie Dam Laursen
KOKim Overvad
Kim Overvad
Marianne Uhre JakobsenMarianne Uhre Jakobsen
Marianne Uhre Jakobsen
Background: Food-based dietary guidelines recommend replacement of whole-fat dairy products with low-fat variants based on data suggesting that diets high in saturated fat are associated with a higher risk of ischemic heart disease. However, the health effects of saturated fat may depend on the source. Objectives: The aim was to investigate substitutions between different subgroups of dairy products and the risk of myocardial infarction (MI). Methods: Data were from the Danish Diet, Cancer and Health cohort and included 54,903 men and women aged 50-64 y at enrollment and without an MI diagnosis. Information about intake of dairy products was obtained by a semiquantitative food-frequency questionnaire. Incident MI cases were identified through nationwide registries. We used Cox proportional hazards regression to estimate associations between specified substitutions of dairy products and MI risk. Results: During a median follow-up of 15.9 y, 3033 cases were identified. Whole-fat yogurt products in place of low-fat or whole-fat milk were associated with a lower risk of MI (HR: 0.89; 95% CI: 0.80, 0.99 per 200 g/d replaced; and HR: 0.87; 95% CI: 0.78, 0.98 per 200 g/d replaced, respectively). Substitution of 20 g/d of cheese for 200 g/d of low-fat or whole-fat milk was also associated with a lower risk of MI (HR: 0.96; 95% CI: 0.92, 0.99; and HR: 0.95; 95% CI: 0.89, 0.99, respectively). Conclusions: Among middle-aged Danish men and women, intake of whole-fat yogurt products or cheese in place of milk, regardless of fat content, was associated with a lower risk of development of MI.